1 / 17

Volumizer a new aspect in Aesthetic Medicine

Background. Facial aging is a consequence of multiple interacting factorsIntrinsic ( e.g. chronoaging )Extrinsic ( e.g. photoaging )Dynamic lines ( e.g. activity of facial muscles )Static wrinkles. . Background. Volume deficits resulting from the loss of facial fatSkeletal remodelin

oya
Download Presentation

Volumizer a new aspect in Aesthetic Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Volumizer – a new aspect in Aesthetic Medicine BioScience GmbH Germany

    2. Background Facial aging is a consequence of multiple interacting factors Intrinsic ( e.g. chronoaging ) Extrinsic ( e.g. photoaging ) Dynamic lines ( e.g. activity of facial muscles ) Static wrinkles.

    3. Background Volume deficits resulting from the loss of facial fat Skeletal remodeling

    4. Background Subdermal filler can form a cornerstone of the new facial rejuvenation paradigm. The products have to be - highly covalent - cohesive - smooth

    5. THIXOTROPIC TECHNIQUE This specially designed HA gel has the property of becoming less viscous under pressure (injecting force) and returning immediately to the original viscosity upon ending of the pressure.

    6. THIXOTROPIC TECHNIQUE This innovative manufacturing process allows to build-up this special types of HA gels. The resulting gels have covalent bindings of the molecules and lead to better duration and stability of the product in the tissue. The network from this thixotropic HA molecules reduces also the diffusion rate of the enzyme Hyaluronidase into the matrix. ? The results are excellent visco-elastic properties, an easy way of injection and a long duration inside the tissue.

    7. Hyacorp This medical device is derived from low-molecular-weight ( LMW ) hyaluronic acid As a result, the product has very high viscosity Remaining soft Has the potential for long-term persistance

    8. Hyacorp 1 ml Hyacorp Face contains 20 mg/ml crosslinked hyaluronic acid homogenizid to be very smooth Viscosity 30.000 mPas 1 ml Hyacorp Lips contains 20 mg/ml crosslinked hyaluronic acid homogenizid to be very smooth Viscosity 20.000 mPas

    9. Hyacorp Face and Lips Smooth Highly cohesive Viscous 20 mg/ml Hyaluronic Acid ( Hylan Gel ) Volumizing Filler Family

    10. Hyacorp is… HYACORP Face and Hyacorp Lips are CE approved for volume restoration and contouring of face and lips Certified as a medical device by CE 0297

    11. Hyacorp Face

    12. Type of injection Device

    13. Hyacorp Lips

    14. Type of injection Device Hyacorp Lips: Needle 29 G or 27 G

    15. Type of Anesthesia Local Topical Regional or block

    16. Injection Sites Malar Nasolabial folds Chin Cheeks Lips

    17. Injection technique Linear threading (malar, chin, nasolabial folds) Subdermal or above the periosteum

    18. Thank you for your attention.

More Related